Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis Patients

Yoko Takeda,Hirotaka Komaba,Shunsuke Goto,Hideki Fujii,Michio Umezu,Hirohito Hasegawa,Akira Fujimori,Masato Nishioka,Shinichi Nishi,Masafumi Fukagawa

Effect of Intravenous Saccharated Ferric Oxide on Serum FGF23 and Mineral Metabolism in Hemodialysis Patients

2011

Yoko Takeda
Hirotaka Komaba
Shunsuke Goto
Hideki Fujii
Michio Umezu
Hirohito Hasegawa
Akira Fujimori
Masato Nishioka
Shinichi Nishi
Masafumi Fukagawa

Background/Aims: Fibroblast growth factor-23 (FGF23) plays a central role in the development of hypophosphatemia and inappropriately low 1,25-dihydroxyvitamin D induced by iron ther

Keywords:

Vitamin D and neurology
Parathyroid hormone
Hypophosphatemia
Fibroblast
Iron-deficiency anemia
Fibroblast growth factor
Endocrinology
Hemodialysis
Medicine
Internal medicine
Diabetes mellitus
Saccharated Ferric Oxide
mineral metabolism

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations